-
What Could New Anti-Obesity Drugs Mean for Medicare?
New medications could be transformative for people who struggle with obesity and related medical conditions, but current law prohibits Medicare from covering drugs prescribed for weight loss. This analysis examines the tradeoffs involved if Medicare were to cover them, and what role the Inflation Reduction Act could play in curbing costs.
-
Mpox one year later: Where is the U.S. today?
May 18, 2023 marked one year since a case of mpox (monkeypox) was identified in the United States as a part of a new multi-country outbreak in regions where it had not previously been endemic. This brief provides an overview of the impact of mpox in the U.S. one year later, the federal response to date, and discusses the future outlook.
-
Testimony: Prior Authorization in Medicare Advantage
Jeannie Fuglesten Biniek testified before the Senate Homeland Security and Government Affairs Committee Permanent Subcommittee on Investigations on May 17, 2023 as part of a hearing on Examining Health Care Denials and Delays in Medicare Advantage.
-
We're Hiring!
KFF seeks job applicants at all levels who are interested in joining a hard-working team dedicated to our unique operating style and mission.
new and noteworthy

